Status:
COMPLETED
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
Lead Sponsor:
Alcon Research
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in...
Eligibility Criteria
Inclusion
- Written informed consent
- Diagnosis of bilateral Primary open angle glaucoma or ocular hypertension
- Intra Ocular Pressure above 19 millimeters mercury at screening visit at 8:00 AM
- Stable visual field in last 6 months
- 6 weeks wash out from previous topical medications
Exclusion
- Age
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00471380
Start Date
March 1 2007
Last Update
March 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catania
Catania, Italy, 95123